DBD
DBD
NYSE · Technology

Diebold Nixdorf Inc

$77.86
+1.05 (+1.37%)
As of May 9, 1:27 AM ET ·
Financial Highlights (FY 2026)
Revenue
3.59B
Net Income
89.25M
Gross Margin
26.4%
Profit Margin
2.5%
Rev Growth
+3.2%
D/E Ratio
0.86
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 26.4% 26.4% 62.0% 62.0%
Operating Margin 6.4% 5.7% 23.8% 24.5%
Profit Margin 2.5% 2.4% 21.9% 24.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.59B 3.48B 350.37M 397.27M
Gross Profit 946.79M 917.25M 217.38M 246.48M
Operating Income 228.35M 199.10M 83.22M 97.46M
Net Income 89.25M 77.82M 76.72M 98.58M
Gross Margin 26.4% 26.4% 62.0% 62.0%
Operating Margin 6.4% 5.7% 23.8% 24.5%
Profit Margin 2.5% 2.4% 21.9% 24.8%
Rev Growth +3.2% +3.2% +6.5% +14.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 631.24M 631.24M 538.36M 459.72M
Total Equity 735.02M 735.02M 1.05B 1.01B
D/E Ratio 0.86 0.86 0.51 0.46
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 352.37M 324.31M 102.75M 125.92M
Free Cash Flow 87.64M 93.06M